(Q48940677)

English

Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.

scientific article published in July 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Marshall G

1

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

Kerr S

2

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

Vowels M

3

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

O'Gorman-Hughes D

4

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

White L

5

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

language of work or name

0 references

publication date

1 July 1989

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

The Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

115

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

1

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

156-160

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

On the receiving end--patient perception of the side-effects of cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Cancer Treatment Needs Better Antiemetics

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Mallory-Weiss lesion following cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Antiemetics: neurotransmitter receptor binding predicts therapeutic actions

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Metoclopramide poisoning in children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

The two-period cross-over clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Metoclopramide as an antiemetic agent in pediatric oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Advances in anti-emetic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980354-3

7 January 2021

Identifiers

10.1016/S0022-3476(89)80354-3

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/2661789

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48940677&oldid=1585870192"